# Aciex Therapeutics, Inc. — Form D

Aciex Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-24. The offering totals $3.2M, of which $1.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-04-24
- Form: D
- Accession: 0001415518-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.2M
- Amount sold: $1.6M
- Remaining: $1.6M
- Investors: 7
- Date of first sale: 2014-04-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-216167

## Issuer

- Name: Aciex Therapeutics, Inc.
- CIK: 0001415518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 470 Atlantic Avenue, Boston, MA, 02210
- Phone: 508-439-4946

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Mark Abelson | Director | Boston, MA |
| Les Kaplan | Director | Boston, MA |
| Dayton Misfeldt | Director | Waltham, MA |
| Jake Nunn | Director | Menlo Park, CA |
| Raj Rai | Director | Boston, MA |
| Hal Werner | Director | Boston, MA |
| Thomas Cavanagh | Executive Officer | Boston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2011-08-11](https://search.stillhousedata.com/formd/0001415518-11-000007) | D | $8.0M | $8.0M |

## More

- [CIK 1415518 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1415518&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001415518-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.